French drug giant Sanofi to give U.S. preference on coronavirus vaccine

over 5 years in thestar

Sanofi’s chief executive officer Paul Hudson says the U.S. was first in line to fund Sanofi’s vaccine research due to financial backing. But he warned that Europe risks falling behind unless it steps up efforts to seek protection against a pandemic that’s killed more than 290,000 people worldwide.

Mentioned in this news
Share it on